SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.
Saved in:
| Title: | SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. |
|---|---|
| Authors: | Dopfer-Jablonka A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany., Steffens S; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Müller F; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany., Mikuteit M; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Niewolik J; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Cossmann A; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Stankov MV; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Behrens GMN; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany.; CiiM-Centre for Individualised Infection Medicine, Hannover, Germany., Hummers E; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany., Heesen G; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany., Schröder D; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany. dominik.schroeder@med.uni-goettingen.de., Roder S; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany., Klawonn F; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany.; Department of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany., Vahldiek K; Department of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany., Hasenkamp J; Clinic for Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Kallusky J; Clinic for Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Falk CS; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany.; Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany., Overbeck TR; Clinic for Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Heinemann S; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2022 Apr 25; Vol. 22 (1), pp. 403. Date of Electronic Publication: 2022 Apr 25. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-022-07347-w |
